DAVIDSON DAVID (Chief Medical Officer) sold 8.1% of their position (3.21K shares) of BLUEBIRD BIO, INC. on the open market
Open‑market sale worth $144.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/8/2021ACC: 0001562180-21-000266
Officer· Chief Medical Officer
Since Jul 2018
-3.21K
Net shares
Net seller
$144.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−48.00
Price / share
$44.95
Trade value
$2.16K
% of position
0.1%
1/5/2021
39.58K→39.53K
Common Stock
Direct
Shares
−1.84K
Price / share
$44.76
Trade value
$82.49K
% of position
4.7%
1/6/2021
39.53K→37.69K
Common Stock
Direct
Shares
−1.32K
Price / share
$45.46
Trade value
$60.19K
% of position
3.5%
1/6/2021
37.69K→36.36K
Total
Net shares
−3.21K
Net value
-$144.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2021 | S · Sale | −48.00 | $44.95 | $2.16K | 0.1% | 39.58K | 39.53K |
| Common Stock Direct | 1/6/2021 | S · Sale | −1.84K | $44.76 | $82.49K | 4.7% | 39.53K | 37.69K |
| Common Stock Direct | 1/6/2021 | S · Sale | −1.32K | $45.46 | $60.19K | 3.5% | 37.69K | 36.36K |
| Total | −3.21K | -$144.84K | ||||||
Derivative Transactions0
No derivative transactions reported